Research targeting TGF-β1 and its associated Smad2/3 signaling pathway has demonstrated a reduction in the phosphorylation of Smad2/3, effectively inhibiting renal fibrosis [29]. This evidence concerns the gene TGFB1 and renal fibrosis.